Revenue: The sum of all revenue fields included for a company's operating activities.
Takeda Pharmaceutical Co. (TAK) had Revenue of $30.24B for the most recently reported fiscal year, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$30.24B |
$712.32M |
|
$10.43B |
|
$19.81B |
|
$27.98B |
|
$2.26B |
|
$-1.11B |
|
$1.16B |
|
$1.16B |
|
$713.74M |
|
$713.74M |
|
$713.74M |
|
$713.74M |
|
$2.26B |
|
$7.29B |
|
3.16B |
|
3.16B |
|
$0.23 |
|
$0.22 |
|
| Balance Sheet Financials | |
$16.64B |
|
$12.99B |
|
$77.40B |
|
$94.04B |
|
$16.54B |
|
$26.18B |
|
$31.72B |
|
$48.26B |
|
$45.78B |
|
$-13.33B |
|
$45.78B |
|
3.15B |
|
| Cash Flow Statement Financials | |
$6.98B |
|
$-2.42B |
|
$-4.96B |
|
$3.02B |
|
$2.54B |
|
$-479.73M |
|
$480.92M |
|
$-2.00B |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|